TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive Mendelsohn Defends ImClone’s Actions And His Role In Development of C225 October 18, 2002
TCL Archive In Brief: Columbia University Double Lab Space; GM Cancer Awards to Suit, Folkman, Nurse June 6, 1997